Two Sigma Advisers’s Phio Pharmaceuticals PHIO Stock Holding History

Two Sigma Advisers’s Portfolio PHIO Stock Details PHIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-432	Closed	-$41K	–	2832
2022 Q1	$41K	Sell	432 -1,537	-78%	-$146K	﹤0.01%	2611
2021 Q4	$213K	Buy	1,969 +551	+39%	+$87.6K	﹤0.01%	2267
2021 Q3	$311K	Buy	1,418 +885	+166%	+$185K	﹤0.01%	2105
2021 Q2	$130K	Buy	533 +260	+95%	+$64.1K	﹤0.01%	2321
2021 Q1	$79K	Sell	273 -354	-56%	-$118K	﹤0.01%	2465
2020 Q4	$182K	Buy	+627	New	+$158K	﹤0.01%	2193

Other funds holding PHIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Advisers's PHIO Position: Q2 2022 in Review

Two Sigma Advisers sold out of Phio Pharmaceuticals (PHIO) in Q2 2022, closing a stake of 432 shares — an estimated $41K sold.

Two Sigma Advisers first reported a position in PHIO in Q4 2020 and held it in 6 quarters. The position peaked at $311K in Q3 2021. 12 funds tracked by Wall St. Rank hold PHIO as of Q2 2022.

Two Sigma Advisers reported no remaining Phio Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
Two Sigma Advisers sold 432 Phio Pharmaceuticals shares in Q2 2022, an estimated $41K.
Two Sigma Advisers first reported a position in Phio Pharmaceuticals in Q4 2020 and held it in 6 quarters.
Two Sigma Advisers's Phio Pharmaceuticals position peaked at $311K in Q3 2021.
12 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q2 2022.

Based on Two Sigma Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.